FDA Should Stick to Safety

David R. Henderson I Blog to Differ June 3, 2026
FDA Should Stick to Safety
AP
Here’s a solution: Remove efficacy from the FDA’s approval process and focus on safety alone.


Comment
Show comments Hide Comments


Related Articles


Copyright © RealClearHealth, LLC
© RealClearHealth | | Go to full site